References
-
1) FGF1 reduces cartilage injury in osteoarthritis via regulating AMPK/Nrf2 pathway.
-
2) Withaferin A inhibits ferroptosis and protects against intracerebral hemorrhage.
-
3) Maf1 mitigates sevoflurane-induced microglial inflammatory damage and attenuates microglia-mediated neurotoxicity in HT-22 cells by activating the AMPK/Nrf2 signaling.
Year: 2022Journal: NEUROTOXICOLOGYImpactFactor: 3.4DOI: 10.1016/j.neuro.2022.04.003PMID: 35430185 -
4) Increased S. Aureus Colonization and Reduced Antimicrobial Peptide Expression in Erythrodermic Psoriasis.
Product: Ribonuclease 7 Antibody (#DF14437)Year: 2024Journal: Int ImmunopharmacolImpactFactor: 5.6DOI: 10.1016/j.intimp.2023.111343PMID: 38096593 -
5) Alleviated NCOA4-mediated ferritinophagy protected RA FLSs from ferroptosis in lipopolysaccharide-induced inflammation under hypoxia.
Product: IREB2 Antibody (#DF14436)Year: 2024Journal: Inflamm ResImpactFactor: 6.7DOI: 10.1007/s00011-023-01842-9PMID: 38189810 -
6) Single‐cell and spatial analyses reveal the association between gene expression of glutamine synthetase with the immunosuppressive phenotype of APOE+CTSZ+TAM in cancers.
Product: Cathepsin Z Antibody (#DF14386)Year: 2023Journal: MOL ONCOLImpactFactor: 6.6DOI: 10.1002/1878-0261.13373PMID: 36587392 -
7) Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma.
Product: CLEC1B Antibody (#DF14376)Year: 2023Journal: Cancer Cell IntImpactFactor: 5.8DOI: 10.1186/s12935-023-02939-1PMID: 37308868 -
8) Self-Assembled Immunostimulatory Nanodrug Combined with PD-L1 for Boosting Anti-Tumor Chemoimmunotherapy.
-
9) Multistage Cooperative Nanodrug Combined with PD‐L1 for Enhancing Antitumor Chemoimmunotherapy.
Product: DNase I Antibody (#DF14243)Year: 2021Journal: ADV HEALTHC MATERImpactFactor: 10DOI: 10.1002/adhm.202101199PMID: 34382363 -
10) SLC39A14 may be a characteristic gene affecting the development of Barrett's esophagus.
Product: SLC39A14 Antibody (#DF14224)Year: 2023Journal: Research SquareDOI: 10.21203/rs.3.rs-3224247/v1 -
11) Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma.
Product: SLC39A14 Antibody (#DF14224)Year: 2023Journal: J CANCERImpactFactor: 3.9DOI: 10.7150/jca.68568PMID: 35371305 -
12) Low–Molecular Weight Fucoidan Polysaccharide Inhibits Pulmonary Fibrosis by Regulating M1/M2 Macrophages Polarization.
Product: RELM beta Antibody (#DF13943)Year: 2022Journal: Research SquareDOI: 10.21203/rs.3.rs-1875874/v1 -
13) ONECUT2 which is targeted by hsa-miR-15a-5p enhances stemness maintenance of gastric cancer stem cells.
Product: ONECUT2 Antibody (#DF13779)Year: 2021Journal: EXP BIOL MEDImpactFactor: 3.2DOI: 10.1177/15353702211038496PMID: 34365839 -
14) Histological Study on the Possible Ameliorating Consequence of Blocking STAT-3 Pathway on Psoriasis Model in Adult Male Albino rat.
Product: IL23 Antibody (#DF13760)Year: 2023Journal: Egyptian Journal of Medical ResearchDOI: 10.21608/ejmr.2023.214067.1397 -
15) CKLF1, transcriptionally activated by FOXC1, promotes hypoxia/reoxygenation‑induced oxidative stress and inflammation in H9c2 cells by NLRP3 inflammasome activation.